Dermtest is a Berlin-based company that provides a telemedicine platform for early detection of skin cancer. Their platform enables family doctors to use teledermatology software and diagnostic hardware to identify early changes in moles that could develop into malignant skin tumors. By connecting family doctors with dermatologists, Dermtest allows for dermatologist consultations at a patient's local primary care clinic. Their SaaS platform includes decision support and patient outcome capturing functionalities, making it a valuable tool for healthcare providers in managing visual information on a person's health. Dermtest serves various healthcare settings, from small practices to large health systems, and focuses on skin cancer, chronic wounds, and psoriasis.